ID

13595

Description

Shorter Radiation Schedule for the Treatment of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00201916

Link

https://clinicaltrials.gov/show/NCT00201916

Keywords

  1. 2/18/16 2/18/16 -
Uploaded on

February 18, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00201916

Eligibility Prostate Cancer NCT00201916

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of adenocarcinoma of the prostate with no evidence of metastatic disease to the nodes, bone or lung
Description

prostate carcinoma, no metastases

Data type

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0027627
stage t1a moderately or poorly differentiated, t1b, t1c or t2 by the current uicc-tnm classification
Description

tumor stage

Data type

boolean

Alias
UMLS CUI [1]
C1300072
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
psa > 40 mcg/l
Description

psa

Data type

boolean

Alias
UMLS CUI [1]
C0138741
previous therapy for carcinoma of the prostate other than biopsy or turp, including patients previously on hormone therapy for treatment of their prostate cancer
Description

previous treatment

Data type

boolean

Alias
UMLS CUI [1]
C0087111
UMLS CUI [2]
C0600139
prior or active malignancy other than non-melanoma skin cancer; or colon or thyroid cancer treated a minimum of five years prior to study entry and presumed cured
Description

malignancies

Data type

boolean

Alias
UMLS CUI [1]
C0006826
simulated volume exceeds 1000 cm3
Description

tumor volume

Data type

boolean

Alias
UMLS CUI [1]
C0475276
previous pelvic radiotherapy
Description

previous pelvic radiotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0030797
inflammatory bowel disease
Description

inflammatory bowel disease

Data type

boolean

Alias
UMLS CUI [1]
C0021390
serious non-malignant disease which would preclude radiotherapy or surgical biopsy
Description

comorbidity precluding radiotherapy or surgical biopsy

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
geographic inaccessibility for follow-up
Description

geographic inaccessibility for follow-up

Data type

boolean

Alias
UMLS CUI [1]
C1321605
psychiatric or addictive disorder which would preclude obtaining informed consent or adherence to protocol
Description

psychiatric or addictive disorder precluding consent or compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
unable to commence radiation therapy within 26 weeks of the date of last prostatic biopsy
Description

unable to commence radiation therapy within 26 weeks

Data type

boolean

Alias
UMLS CUI [1]
C1321605
failure to give informed consent to participate in the study
Description

failure to give informed consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0439801

Similar models

Eligibility Prostate Cancer NCT00201916

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
prostate carcinoma, no metastases
Item
histologic diagnosis of adenocarcinoma of the prostate with no evidence of metastatic disease to the nodes, bone or lung
boolean
C0600139 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
tumor stage
Item
stage t1a moderately or poorly differentiated, t1b, t1c or t2 by the current uicc-tnm classification
boolean
C1300072 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
psa
Item
psa > 40 mcg/l
boolean
C0138741 (UMLS CUI [1])
previous treatment
Item
previous therapy for carcinoma of the prostate other than biopsy or turp, including patients previously on hormone therapy for treatment of their prostate cancer
boolean
C0087111 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
malignancies
Item
prior or active malignancy other than non-melanoma skin cancer; or colon or thyroid cancer treated a minimum of five years prior to study entry and presumed cured
boolean
C0006826 (UMLS CUI [1])
tumor volume
Item
simulated volume exceeds 1000 cm3
boolean
C0475276 (UMLS CUI [1])
previous pelvic radiotherapy
Item
previous pelvic radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C0030797 (UMLS CUI [1,2])
inflammatory bowel disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
comorbidity precluding radiotherapy or surgical biopsy
Item
serious non-malignant disease which would preclude radiotherapy or surgical biopsy
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
geographic inaccessibility for follow-up
Item
geographic inaccessibility for follow-up
boolean
C1321605 (UMLS CUI [1])
psychiatric or addictive disorder precluding consent or compliance
Item
psychiatric or addictive disorder which would preclude obtaining informed consent or adherence to protocol
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
unable to commence radiation therapy within 26 weeks
Item
unable to commence radiation therapy within 26 weeks of the date of last prostatic biopsy
boolean
C1321605 (UMLS CUI [1])
failure to give informed consent
Item
failure to give informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial